Seeing Is Believing

Currently out of the existing stock ratings of Nigel Dally, 71 are a SELL (14.79%), 233 are a HOLD (48.54%), 176 are a BUY (36.67%).
Analyst Nigel Dally, carries an average stock price target met ratio of 72.97% that have a potential upside of 36.4% achieved within 297 days. Previously, Nigel Dally worked at MORGAN STANLEY.
Nigel Dally’s has documented 966 price targets and ratings displayed on 24 stocks. The coverage was on Financial Services, Healthcare, Communication Services, Basic Materials sectors.
Most recent stock forecast was given on MOS, The Mosaic Company at 14-Jan-2026.
Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS ).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS ) at 11/13/2023. The price target of $10 was fulfilled within 106 days with a profit of $7.89 (373.93%) receiving and performance score of 35.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Jan-2019
$105
$-9.03 (-7.92%)
$100
1 months 19 days ago
(05-Jan-2026)
11/17 (64.71%)
$-7.19 (-6.41%)
259
Hold Since 20-Mar-2023
$102
$-12.03 (-10.55%)
$74
2 months 2 days ago
(22-Dec-2025)
2/3 (66.67%)
$-8.05 (-7.31%)
26
Sell Since 04-Dec-2020
$104
$-10.03 (-8.80%)
$47
2 months 8 days ago
(16-Dec-2025)
3/4 (75%)
$-5.49 (-5.01%)
43
$120
$5.97 (5.24%)
$118
2 months 9 days ago
(15-Dec-2025)
34/37 (91.89%)
$8.5 (7.62%)
299
Hold Since 09-Jun-2023
$115
$0.97 (0.85%)
$110
3 months 13 days ago
(11-Nov-2025)
9/9 (100%)
$1.8 (1.59%)
189
Which stock is Nigel Dally is most bullish on?
Which stock is Nigel Dally is most reserved on?
What Year was the first public recommendation made by Nigel Dally?